Clinical Trials Browser

Glioblastoma, Glioma

Glioblastoma

Glioblastoma, Recurrence

Glioblastoma, Neoplasms

Brain Neoplasms, Glioblastoma

Glioblastoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Glioblastoma

Glioblastoma

Brain Neoplasms, Glioblastoma

Brain Neoplasms, Glioblastoma, Glioma

Glioblastoma

Glioblastoma

Glioblastoma, Glioma

Glioblastoma, Recurrence

Brain Neoplasms, Glioblastoma

Glioblastoma

Glioblastoma, Glioma, Neoplasms

Glioblastoma

Glioblastoma

Glioblastoma, Glioma

Glioblastoma, Recurrence, Disease Progression

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Astrocytoma, Glioblastoma, Oligodendroglioma

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma, Stress, Psychological

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma, Leukemia, B-Cell

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neuroepithelial

Glioblastoma

Glioblastoma, Glioma

Glioblastoma

Glioblastoma

Glioblastoma

Colonic Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Medulloblastoma

Glioblastoma

Glioblastoma, Neoplasms

Glioblastoma, Glioma

Glioblastoma, Glioma

Clinical Trials

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients

BORTEM-17

Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma

Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma

The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma

Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas

GLIODRUG-V

POBIG

ImPRESS

HITCH

Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients

A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma

MIRROR

TaRRGET

OptimalTTF-2

MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype

2253

RE-GEND

Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab

Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma

Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma

TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study

Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma

LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?

Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning

A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme

Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme

GEHIRN

Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients

Personalized Trial in ctDNA-level-relapse Glioblastoma

GBM

TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma

Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme

PLANET

HIT-HGG-2013

FUTURE-GB

The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.

Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

CSREIG

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients

A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme

CARTREMENDOUS

Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme